Mutation screening of C1 inhibitor gene in 108 unrelated families with hereditary angioedema: Functional and structural correlates

Emanuela Pappalardo, Sonia Caccia, Chiara Suffritti, A. Tordai, Lorenza Chiara Zingale, Marco Cicardi

Research output: Contribution to journalArticle

81 Citations (Scopus)

Abstract

Hereditary angioedema (HAE) is an autosomal dominant disorder characterized by the deficiency of the inhibitor of the first component of complement system (C1-INH), which is due to mutations in its structural gene. There are two phenotypic variants: HAE type I, with reduced plasma antigen levels and HAE type II with normal antigen levels and reduced functional C1 inhibitor activity. The aim of this study was to determine the disease-causing mutations in 108 unrelated HAE families, followed at a single center in Italy, and in 50 normal controls by a genetic screening strategy of the C1-INH gene (SERPIN1G). To detect small mutations we either used fluorescence assisted mismatch analysis, followed by sequencing, or direct sequencing. Patients negative for mutations at this screening were further analyzed by long-range PCR to detect the presence of large deletions or insertions. Overall we identified 81 different mutations possibly responsible for the disease in 102 families, in the remaining 6 families no mutation was detected except for a synonymous substitution in a single probant. Sixty-seven of these mutations (23 missense, 22 frameshift, 8 splicing defects, 8 nonsense and 6 large insertion/deletions) had not been previously published. In addition, 4 rare variants, 2 synonymous alterations and 1 new polymorphism in the 3′UTR of the C1-INH gene were found. Mutations were distributed over all exons, at splice sites and in introns. Our study identified a large number of new mutations related to HAE providing additional evidence of the genetic heterogeneity of this disease. Our results also point toward particular amino acid residues important for protein function that may represent mutation hot spots.

Original languageEnglish
Pages (from-to)3536-3544
Number of pages9
JournalMolecular Immunology
Volume45
Issue number13
DOIs
Publication statusPublished - Aug 2008

Fingerprint

Hereditary Angioedemas
Mutation
Genes
Hereditary Angioedema Types I and II
Complement C1
Antigens
Inborn Genetic Diseases
Genetic Heterogeneity
Genetic Testing
Missense Mutation
Introns
Italy
Exons
Fluorescence
Amino Acids
Polymerase Chain Reaction

Keywords

  • C1 inhibitor
  • Complement
  • Hereditary angioedema
  • Mutations
  • Serpins

ASJC Scopus subject areas

  • Molecular Biology
  • Immunology

Cite this

Mutation screening of C1 inhibitor gene in 108 unrelated families with hereditary angioedema : Functional and structural correlates. / Pappalardo, Emanuela; Caccia, Sonia; Suffritti, Chiara; Tordai, A.; Zingale, Lorenza Chiara; Cicardi, Marco.

In: Molecular Immunology, Vol. 45, No. 13, 08.2008, p. 3536-3544.

Research output: Contribution to journalArticle

Pappalardo, Emanuela ; Caccia, Sonia ; Suffritti, Chiara ; Tordai, A. ; Zingale, Lorenza Chiara ; Cicardi, Marco. / Mutation screening of C1 inhibitor gene in 108 unrelated families with hereditary angioedema : Functional and structural correlates. In: Molecular Immunology. 2008 ; Vol. 45, No. 13. pp. 3536-3544.
@article{c7b5f5617d8f4ec7a009d205e8d58e03,
title = "Mutation screening of C1 inhibitor gene in 108 unrelated families with hereditary angioedema: Functional and structural correlates",
abstract = "Hereditary angioedema (HAE) is an autosomal dominant disorder characterized by the deficiency of the inhibitor of the first component of complement system (C1-INH), which is due to mutations in its structural gene. There are two phenotypic variants: HAE type I, with reduced plasma antigen levels and HAE type II with normal antigen levels and reduced functional C1 inhibitor activity. The aim of this study was to determine the disease-causing mutations in 108 unrelated HAE families, followed at a single center in Italy, and in 50 normal controls by a genetic screening strategy of the C1-INH gene (SERPIN1G). To detect small mutations we either used fluorescence assisted mismatch analysis, followed by sequencing, or direct sequencing. Patients negative for mutations at this screening were further analyzed by long-range PCR to detect the presence of large deletions or insertions. Overall we identified 81 different mutations possibly responsible for the disease in 102 families, in the remaining 6 families no mutation was detected except for a synonymous substitution in a single probant. Sixty-seven of these mutations (23 missense, 22 frameshift, 8 splicing defects, 8 nonsense and 6 large insertion/deletions) had not been previously published. In addition, 4 rare variants, 2 synonymous alterations and 1 new polymorphism in the 3′UTR of the C1-INH gene were found. Mutations were distributed over all exons, at splice sites and in introns. Our study identified a large number of new mutations related to HAE providing additional evidence of the genetic heterogeneity of this disease. Our results also point toward particular amino acid residues important for protein function that may represent mutation hot spots.",
keywords = "C1 inhibitor, Complement, Hereditary angioedema, Mutations, Serpins",
author = "Emanuela Pappalardo and Sonia Caccia and Chiara Suffritti and A. Tordai and Zingale, {Lorenza Chiara} and Marco Cicardi",
year = "2008",
month = "8",
doi = "10.1016/j.molimm.2008.05.007",
language = "English",
volume = "45",
pages = "3536--3544",
journal = "Molecular Immunology",
issn = "0161-5890",
publisher = "Elsevier Limited",
number = "13",

}

TY - JOUR

T1 - Mutation screening of C1 inhibitor gene in 108 unrelated families with hereditary angioedema

T2 - Functional and structural correlates

AU - Pappalardo, Emanuela

AU - Caccia, Sonia

AU - Suffritti, Chiara

AU - Tordai, A.

AU - Zingale, Lorenza Chiara

AU - Cicardi, Marco

PY - 2008/8

Y1 - 2008/8

N2 - Hereditary angioedema (HAE) is an autosomal dominant disorder characterized by the deficiency of the inhibitor of the first component of complement system (C1-INH), which is due to mutations in its structural gene. There are two phenotypic variants: HAE type I, with reduced plasma antigen levels and HAE type II with normal antigen levels and reduced functional C1 inhibitor activity. The aim of this study was to determine the disease-causing mutations in 108 unrelated HAE families, followed at a single center in Italy, and in 50 normal controls by a genetic screening strategy of the C1-INH gene (SERPIN1G). To detect small mutations we either used fluorescence assisted mismatch analysis, followed by sequencing, or direct sequencing. Patients negative for mutations at this screening were further analyzed by long-range PCR to detect the presence of large deletions or insertions. Overall we identified 81 different mutations possibly responsible for the disease in 102 families, in the remaining 6 families no mutation was detected except for a synonymous substitution in a single probant. Sixty-seven of these mutations (23 missense, 22 frameshift, 8 splicing defects, 8 nonsense and 6 large insertion/deletions) had not been previously published. In addition, 4 rare variants, 2 synonymous alterations and 1 new polymorphism in the 3′UTR of the C1-INH gene were found. Mutations were distributed over all exons, at splice sites and in introns. Our study identified a large number of new mutations related to HAE providing additional evidence of the genetic heterogeneity of this disease. Our results also point toward particular amino acid residues important for protein function that may represent mutation hot spots.

AB - Hereditary angioedema (HAE) is an autosomal dominant disorder characterized by the deficiency of the inhibitor of the first component of complement system (C1-INH), which is due to mutations in its structural gene. There are two phenotypic variants: HAE type I, with reduced plasma antigen levels and HAE type II with normal antigen levels and reduced functional C1 inhibitor activity. The aim of this study was to determine the disease-causing mutations in 108 unrelated HAE families, followed at a single center in Italy, and in 50 normal controls by a genetic screening strategy of the C1-INH gene (SERPIN1G). To detect small mutations we either used fluorescence assisted mismatch analysis, followed by sequencing, or direct sequencing. Patients negative for mutations at this screening were further analyzed by long-range PCR to detect the presence of large deletions or insertions. Overall we identified 81 different mutations possibly responsible for the disease in 102 families, in the remaining 6 families no mutation was detected except for a synonymous substitution in a single probant. Sixty-seven of these mutations (23 missense, 22 frameshift, 8 splicing defects, 8 nonsense and 6 large insertion/deletions) had not been previously published. In addition, 4 rare variants, 2 synonymous alterations and 1 new polymorphism in the 3′UTR of the C1-INH gene were found. Mutations were distributed over all exons, at splice sites and in introns. Our study identified a large number of new mutations related to HAE providing additional evidence of the genetic heterogeneity of this disease. Our results also point toward particular amino acid residues important for protein function that may represent mutation hot spots.

KW - C1 inhibitor

KW - Complement

KW - Hereditary angioedema

KW - Mutations

KW - Serpins

UR - http://www.scopus.com/inward/record.url?scp=46749122195&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=46749122195&partnerID=8YFLogxK

U2 - 10.1016/j.molimm.2008.05.007

DO - 10.1016/j.molimm.2008.05.007

M3 - Article

C2 - 18586324

AN - SCOPUS:46749122195

VL - 45

SP - 3536

EP - 3544

JO - Molecular Immunology

JF - Molecular Immunology

SN - 0161-5890

IS - 13

ER -